Detecting Auricular Points in OFP by a Novel APD ( APD-OFP)
Detecting Auricular Points Among Patients With Orofacial Pain by A Novel Auricular Point Detector (APD): A Pilot Diagnostic Accuracy Study
1 other identifier
observational
24
1 country
1
Brief Summary
This is a pilot diagnostic accuracy study conducted to assess the diagnostic ability of a novel APD for auricular point detection among patients with orofacial pain, as compared with an already commercialized device.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 8, 2018
CompletedFirst Posted
Study publicly available on registry
October 10, 2018
CompletedStudy Start
First participant enrolled
October 15, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2019
CompletedOctober 10, 2018
October 1, 2018
4 months
October 8, 2018
October 8, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
cohen's kappa coefficient
The Cohen's kappa coefficient is a statistical test used to validate the inter-method reliability, test-retest reliability and inter-observer reliability of the device in detecting OFP-related auricular point.
baseline
Secondary Outcomes (5)
the Visual Analogue Scale (VAS)
baseline
the Penn Facial Pain Scale-Revised (Penn-FPS-R)
baseline
self-developed questionnaire on patient's attitude towards complementary therapies for pain management
baseline
The diagnostic specificity of the device
baseline
The diagnostic sensitivity of the device
baseline
Study Arms (2)
Orofacial pain group
Patients in this group will receive auricular point detection which is accomplished by the novel auricular point detector device. There is no addition to the patient's routine care.
Control group
This group includes healthy subject, for whom no treatment will be performed. Only auricular point detection by the auricular point detector will be conducted.
Interventions
This device is only for auricular detection. No additional intervention will be delivered.
Eligibility Criteria
OFP patients visiting the inpatient or outpatient unit of the Department of Anesthesiology Queen Mary Hospital will be referred to this study by an anesthesiologist.
You may qualify if:
- When pain attacks, the average unilateral orofacial pain severity \>=5 point measured by a 10-point VAS scale;
- Patient with trigeminal neuralgia can be diagnosed according to Trigeminal neuralgia: New classification and diagnostic grading for practice and research (Neurology, 2016);
- Other kinds of orofacial pain can be diagnosed based on the patient's symptoms;
- Provide written inform consent;
- Free of any other diagnosed psychological conditions;
You may not qualify if:
- with any other diseases such as cardiovascular, renal, neurological, digestive, hepatic, respiratory disease;
- Pregnancy or lactation;
- Participation in a clinical study that may interfere with participation in this study;
- History of or current tobacco, alcohol use;
- Anything that would place the individual at increased risk or preclude the individual's full compliance with or completion of the study;
- Unable to provide written informed consent due to any reason;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The University of Hong Konglead
- Queen Mary Hospital, Hong Kongcollaborator
- City University of Hong Kongcollaborator
Study Sites (1)
Queen Mary Hospital, HKU
Hong Kong, INTL, 852, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lixing Lao, PhD
The University of Hong Kong
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Target Duration
- 15 Days
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 8, 2018
First Posted
October 10, 2018
Study Start
October 15, 2018
Primary Completion
January 31, 2019
Study Completion
March 31, 2019
Last Updated
October 10, 2018
Record last verified: 2018-10
Data Sharing
- IPD Sharing
- Will not share
IPD sharing will be at the discretion of the study-involved participants and the principal investigator.